Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 4
Abstract
Objective: Prostate carcinoma (PC) is one of the most commonly diagnosed cancer types with significant rates of mortality and morbidity. The etiology of PC is not clear. Cytokine and mediators at the inflammatory pathway plays role at the various steps of the relation between chronic inflammation and cancer. The objective of this study is to determine if there is relationship between cyclooxygenase-2 (COX) apoptosis and angiogenesis in patients with PC. Materials and Methods: Sample of 49 cases who were at pathologic stage pT2 and underwent radical prostatectomy, were selected retrospectively between 2005-2010, from the archives of Pathology Department of Çukurova University Faculty of Medicine. Histologic slides of each case were reviewed for the diagnostic reassessment and graded by the Gleason scoring system. COX-2, vascular endothelial growth factor (VEGF), monoclonal antibody (M30) and bcl-2 were immunohistochemically applied to the cases and they were evaluated. Results: The mean age of the patients were 63.8. Twenty-one cases had their Gleason score ≤6 and 28 had their Gleason score ≥7. COX-2 expression was detected in 81.6% of cases. While COX-2 expression was significantly correlated with bcl-2 expression, there was no correlation between VEGF and COX-2 expression. Gleason score was negatively correlated with M30. It was detected that as COX-2 expression increased mean survival time significantly decreased. Conclusion: This study makes us think that in the PC carcinogenesis COX-2 inhibits apoptosis rather than promoting angiogenesis. These results may offer new insights for the treatment strategies, also they may be useful for the prediction of clinical outcomes.
Authors and Affiliations
Emine Kılıç Bağır, Arbil Açıkalın, Volkan İzol, Gülşah Şeydaoğlu, Şeyda Erdoğan
Reflection of Adjuvant Treatment Approaches for Early Stage Testis Tumors in Our Clinic
Objective: Treatment modalities applied after orchiectomy in early-stage germ cell tumors (GCTs) include significant changes in each new study. In this study we reevaluated the treatment approaches used in our hospital b...
Oncocytic Adrenocortical Carcinoma: A Rare Case Report
Oncocytic neoplasms of the adrenal cortex are uncommon and generally benign and non-functioning. About 20% of adrenocortical oncocytic neoplasms show malignant components. A 39-year-old woman with an adrenocortical oncoc...
Transperitoneal Laparoscopic Nephrectomy-Our Initial Experiences
Objective: To evaluate the first experiences of laparoscopic nephrectomy operations performed in our clinics. Materials and Methods: A total of 61 laparoscopic nephrectomy operations were performed in our clinics during...
Genomic Evaluation of Testicular Germ Cell Tumors and its Role in Treatment Planning
The incidence of testicular germ cell tumors (TGCT) has significantly increased over the last 40 years and continues to increase among the young male population. The geographical differences show that a combination of ge...
Incidentally Found Paratesticular Rhabdomyosarcoma: Case Report
Paratesticular rhabdomyosarcomas (RMS) constitute 7% of all RMS. Paratesticular RMS are malignant tumors and although many of them are seen in children and adolescents, 24% of them are seen in adults. A patient in the ol...